Key Record Dates
ClinicalTrials.gov Identifier: | NCT03524508 |
---|---|
Brief Title: | Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer |
First Submitted : | April 18, 2018 |
First Submitted that Met QC Criteria : | May 11, 2018 |
First Posted : | May 14, 2018 |
Last Update Submitted that Met QC Criteria : | August 22, 2022 |
Last Update Posted : | August 24, 2022 |